Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann Neuzillet

Showing results (51-60 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 11, 2012
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugsMathieu Rouanne, Christophe Massard, Antoine Hollebecque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2008
Prostate cancer in renal transplant recipientsFrançois Kleinclauss, Marc Gigante, Yann Neuzillet, et al.
Molecular & Cellular Oncology|June 17, 2016
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancersThierry Lebret, Yann Neuzillet, Nadine Houede, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
World Journal of Urology|June 2, 2018
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathwaysMathieu Rouanne, Mathieu Roumiguié, Nadine Houédé, et al.
Future Oncology (London, England)|February 5, 2021
Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysisMathieu Roumiguié, Xavier Paoletti, Yann Neuzillet, et al.
Urologic Oncology|July 16, 2014
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytologyYann Neuzillet, Charlotte Methorst, Marc Schneider, et al.
Annals of Surgical Oncology|January 2, 2014
Long-term women-reported quality of life after radical cystectomy and orthotopic ileal neobladder reconstructionMathieu Rouanne, Guillaume Legrand, Yann Neuzillet, et al.
World Journal of Urology|February 1, 2021
PSA and obesity among men with localized prostate cancer: results of the ANDROCAN studyMatthias E Meunier, Yann Neuzillet, Jean-François Dreyfus, et al.
The Prostate|September 15, 2017
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial)Yann Neuzillet, Jean-Pierre Raynaud, Camélia Radulescu, et al.
Pageof 15

Showing results (51-60 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Cancer (Oxford, England : 1990)|September 11, 2012
Evaluation of sexuality, health-related quality-of-life and depression in advanced cancer patients: a prospective study in a Phase I clinical trial unit of predominantly targeted anticancer drugsMathieu Rouanne, Christophe Massard, Antoine Hollebecque, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 20, 2008
Prostate cancer in renal transplant recipientsFrançois Kleinclauss, Marc Gigante, Yann Neuzillet, et al.
Molecular & Cellular Oncology|June 17, 2016
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancersThierry Lebret, Yann Neuzillet, Nadine Houede, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2019
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancerMathieu Rouanne, Reem Betari, Camélia Radulescu, et al.
World Journal of Urology|June 2, 2018
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathwaysMathieu Rouanne, Mathieu Roumiguié, Nadine Houédé, et al.
Future Oncology (London, England)|February 5, 2021
Apalutamide, darolutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer: a meta-analysisMathieu Roumiguié, Xavier Paoletti, Yann Neuzillet, et al.
Urologic Oncology|July 16, 2014
Assessment of diagnostic gain with hexaminolevulinate (HAL) in the setting of newly diagnosed non-muscle-invasive bladder cancer with positive results on urine cytologyYann Neuzillet, Charlotte Methorst, Marc Schneider, et al.
Annals of Surgical Oncology|January 2, 2014
Long-term women-reported quality of life after radical cystectomy and orthotopic ileal neobladder reconstructionMathieu Rouanne, Guillaume Legrand, Yann Neuzillet, et al.
World Journal of Urology|February 1, 2021
PSA and obesity among men with localized prostate cancer: results of the ANDROCAN studyMatthias E Meunier, Yann Neuzillet, Jean-François Dreyfus, et al.
The Prostate|September 15, 2017
Sexual steroids in serum and prostatic tissue of human non-cancerous prostate (STERPROSER trial)Yann Neuzillet, Jean-Pierre Raynaud, Camélia Radulescu, et al.
Pageof 15